Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.837
-0.024 (-2.81%)
At close: Apr 28, 2026, 4:00 PM EDT
0.837
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:04 PM EDT
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $9.58 million as of April 28, 2026. Its market cap has increased by 12.59% in one year.
Market Cap
9.58M
Enterprise Value
-4.74M
1-Year Change
12.59%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $9.58M, a decrease of -49.38%. That is a compound annual growth rate of -15.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 9.86M | 65.31% |
| Dec 31, 2025 | 5.97M | -66.64% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imunon | 10.98M |
| BioLineRx | 10.52M |
| Kiora Pharmaceuticals | 10.18M |
| Enveric Biosciences | 10.13M |
| Quoin Pharmaceuticals | 9.85M |
| Evogene | 9.67M |
| Bolt Biotherapeutics | 9.53M |
| CalciMedica | 9.29M |